BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2025-05-31 ms6000001767911714 来自北京

审稿速度:6.0 | 投稿命中率:50.0
经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好

4 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2025-04-04 ms1000001741077445 来自河南

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：疾病动物模型机制
经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。

12 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2025-04-23 ms8000001386851440

偏重的研究方向：分子机制
经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！

9 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2024-05-21 haoy 来自黑龙江省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：心血管病
经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！

77 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2025-02-18 ms9000001939181732 来自湖南省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学
经验分享：9月中旬提交
11月底返回一审建议（无需补实验）
12月底提交返修文稿
2月中旬直接接收
投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。

14 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2024-03-14 ms4000000708642466 来自天津

为什么邀请了60个审稿人还没有人审稿呢

121 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2024-05-18 ms1000000096818640 来自上海

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：分子机制;疾病动物模型
经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…

115 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2024-12-17 ms2000000400327376 来自辽宁省

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：生信分析
经验分享：返修完，一个半小时拒稿让转投，没有理由

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2024-11-30 ms2000001788822132 来自上海

一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。
适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。
审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267445, encodeId=d6e3226e445b7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：返修后审稿人不好找，但可以发催稿信催，编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Sat May 31 08:54:30 CST 2025, time=2025-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259118, encodeId=aa64225911809, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：疾病动物模型机制 经验分享：外审两月，给了两个月大修，修回后10天接收。总共4个半月。审稿人也比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16f8204265, createdName=ms1000001741077445, createdTime=Fri Apr 04 16:32:15 CST 2025, time=2025-04-04, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2261641, encodeId=1ec222616419f, content=偏重的研究方向：分子机制 经验分享：这个期刊有人三个月没有找到审稿人吗，编辑每10天邀请2个，催稿也没有意义！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f5593783, createdName=ms8000001386851440, createdTime=Wed Apr 23 07:38:21 CST 2025, time=2025-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205905, encodeId=277222059055f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：心血管病 经验分享：杂志编辑处理速度很快，很负责任。只是好多审稿人在返修阶段拒绝复审耽误了很长时间，前后找了7个审稿人经历3次大修最终接收。祝所有道友都能科研顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OIjucuWUMmQvav6j0I5CdEjhvRlrabXkUQHZ0Y1bSK5xfhO2BUphept0qVymNvibL6rG4v1Zmic2Wp6jY4Q7GOow/132, createdBy=7bdc5278714, createdName=haoy, createdTime=Tue May 21 20:28:18 CST 2024, time=2024-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2252492, encodeId=774e2252492b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药物敏感性;生信分析;肿瘤分子生物学 经验分享：9月中旬提交 11月底返回一审建议（无需补实验） 12月底提交返修文稿 2月中旬直接接收 投稿过程顺利，但审稿周期较长，一般文章在编辑手里会停留1~2周。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c289606492, createdName=ms9000001939181732, createdTime=Tue Feb 18 14:13:59 CST 2025, time=2025-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193176, encodeId=73ef21931e618, content=为什么邀请了60个审稿人还没有人审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dc06560004, createdName=ms4000000708642466, createdTime=Thu Mar 14 14:39:42 CST 2024, time=2024-03-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2205343, encodeId=6a572205343e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：分子机制;疾病动物模型 经验分享：大家谨慎！编辑送审后审稿人意见都很好，编辑还是拒稿，且要求WB整膜和动物伦理等，十分离谱，浪费一个多月！据说他们杂志基本都送审，然后再编辑评估拒稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Sat May 18 10:32:58 CST 2024, time=2024-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243048, encodeId=cc212243048e3, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：生信分析 经验分享：返修完，一个半小时拒稿让转投，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33d19051353, createdName=ms2000000400327376, createdTime=Tue Dec 17 07:38:08 CST 2024, time=2024-12-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2240122, encodeId=fe242240122f8, content=一本专注于疾病过程及人类疾病模型的生物化学和分子遗传学研究的国际期刊。 适合衰老、癌症、代谢、神经和免疫疾病的各个方面，特别鼓励使用动物模型来阐明这些条件下的生化和机理见解的手稿。 审稿周期相对较长，一般需要2-4个月，有时甚至会更长，还是需要有一定耐心的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:38:01 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111767, encodeId=e6bd2111e671c, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：铁死亡 经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Fri Jan 27 22:28:38 CST 2023, time=2023-01-27, status=1, ipAttribution=上海)]

2023-01-27 ms9000001599932088 来自上海

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：铁死亡
经验分享：11.23投，With Editor到11.29送审，12.9Required Reviews Completed，12.20被拒。两个审稿人，提了些意见，虽然被拒了但是觉得杂志还是不错的，处理速度也相对比较快。

94 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务